Is a complete KROS research report available?

No complete published report is available for Keros Therapeutics, Inc. (KROS) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Keros Therapeutics, Inc. (KROS)

NASDAQ: KROS · USD

$11.6

+0.16 (+1.4%)· Recorded snapshot

Market cap	229.6M
Revenue (ttm)	15M
Net income (ttm)	-83.2M
EPS (ttm)	-$3.10
Shares out	19.8M
Volume	134,425
Beta	1.12

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 15M
Net income (ttm): -83.2M
EPS (ttm): -$3.10
Market cap: 229.6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001664710
Company name	Keros Therapeutics, Inc.
Country	United States
Country code	US
CUSIP number	492327101
Earnings date	2026-11-09
Earnings time	amc
Employees	92
Employees change	-56
Employees growth	-37.84%
Enterprise value	$-12.3M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
In index	RUSSELL2000
Industry	Biotechnology
IPO date	2020-04-08
Is primary listing	Yes
Is SPAC	No
ISIN number	US4923271013
Last 10-K release date	2026-03-04
Last earnings date	2026-08-03
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$229.6M
Market cap category	Micro-Cap
Next earnings date	2026-11-09
Options	Yes
Price	$11.58
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	KROS
U.S. state	Massachusetts
Website	https://www.kerostx.com

Metric

Value

Amount currency

USD

CIK code

0001664710

Company name

Keros Therapeutics, Inc.

Country

United States

Country code

CUSIP number

492327101

Earnings date

2026-11-09

Earnings time

amc

Employees

Employees change

-56

Employees growth

-37.84%

Enterprise value

$-12.3M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2015

In index

RUSSELL2000

Industry

Biotechnology

IPO date

2020-04-08

Is primary listing

Yes

Is SPAC

ISIN number

US4923271013

Last 10-K release date

2026-03-04

Last earnings date

2026-08-03

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$229.6M

Market cap category

Micro-Cap

Next earnings date

2026-11-09

Options

Yes

Price

$11.58

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

KROS

U.S. state

Massachusetts

Website

https://www.kerostx.com

Metric	Value
Earnings yield	-26.81%
FCF / EV yield	315.75%
FCF yield	-21.4%
Forward P/S	15.76x
P/B ratio	0.86x
P/S ratio	15.09x
Price / tangible book value	0.86x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-26.81%

FCF / EV yield

315.75%

FCF yield

-21.4%

Forward P/S

15.76x

P/B ratio

0.86x

P/S ratio

15.09x

Price / tangible book value

0.86x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Operating margin	-655.84%
Pretax margin	-573.44%
Profit per employee	$-903,902
Profitable years	1
Revenue per employee	$163,196
ROA	-11.78%
ROA (5Y)	-17.57%
ROCE	-35.75%
ROE	-17.16%
ROE (5Y)	-27.05%
ROIC	-481.72%
ROIC (5Y)	-774.44%
SBC / revenue	152.3%
Tax / revenue	-19.57%

Metric

Value

Operating margin

-655.84%

Pretax margin

-573.44%

Profit per employee

$-903,902

Profitable years

Revenue per employee

$163,196

ROA

-11.78%

ROA (5Y)

-17.57%

ROCE

-35.75%

ROE

-17.16%

ROE (5Y)

-27.05%

ROIC

-481.72%

ROIC (5Y)

-774.44%

SBC / revenue

152.3%

Tax / revenue

-19.57%

Metric	Value
EPS growth years	2
Net income growth quarters	1
Net income growth years	1
Revenue growth	-93.55%
Revenue growth 5Y	172.46%
Revenue growth years	2

Metric

Value

EPS growth years

Net income growth quarters

Net income growth years

Revenue growth

-93.55%

Revenue growth 5Y

172.46%

Revenue growth years

Metric	Value
Capital expenditures	$-494,000
Depreciation and amortization	$1.6M
EBIT	$-98.5M
EBITDA	$-96.9M
EPS	$-3.10
FCF per share	$-2.45
Financing cash flow	$-384.1M
Free cash flow	$-48.5M
Free cash flow minus SBC	$-71.4M
Gross profit	$-58.3M
Income taxes	$-2.9M
Investing cash flow	$-494,000
Net cash flow	$-432.6M
Net income	$-83.2M
Operating cash flow minus SBC	$-70.9M
Operating income	$-98.5M
Revenue	$15M
Stock-based compensation	$22.9M

Metric

Value

Capital expenditures

$-494,000

Depreciation and amortization

$1.6M

EBIT

$-98.5M

EBITDA

$-96.9M

EPS

$-3.10

FCF per share

$-2.45

Financing cash flow

$-384.1M

Free cash flow

$-48.5M

Free cash flow minus SBC

$-71.4M

Gross profit

$-58.3M

Income taxes

$-2.9M

Investing cash flow

$-494,000

Net cash flow

$-432.6M

Net income

$-83.2M

Operating cash flow minus SBC

$-70.9M

Operating income

$-98.5M

Revenue

$15M

Stock-based compensation

$22.9M

Metric	Value
Altman Z-Score	8.22
Book value per share	$13.23
Debt / equity	0.06
Long-term assets	$20.7M
Long-term liabilities	$13.1M
Net cash (debt)	$241.9M
Net cash / market cap	106.78%
Net cash growth	-64.02%
Net debt / equity	-0.92
Piotroski F-Score	2
Property, plant and equipment	$19.3M
Shareholders' equity	$262.3M
Tangible book value	$262.3M
Tangible book value per share	$13.23
Total assets	$287.6M
Total cash	$257.6M
Total debt	$15.7M
Total liabilities	$25.3M
WACC	9.75%

Metric

Value

Altman Z-Score

8.22

Book value per share

$13.23

Debt / equity

0.06

Long-term assets

$20.7M

Long-term liabilities

$13.1M

Net cash (debt)

$241.9M

Net cash / market cap

106.78%

Net cash growth

-64.02%

Net debt / equity

-0.92

Piotroski F-Score

Property, plant and equipment

$19.3M

Shareholders' equity

$262.3M

Tangible book value

$262.3M

Tangible book value per share

$13.23

Total assets

$287.6M

Total cash

$257.6M

Total debt

$15.7M

Total liabilities

$25.3M

WACC

9.75%

Metric	Value
Asset turnover	0.03
Current assets	$266.9M
Current liabilities	$12.2M
Current ratio	21.96
Net working capital	$-279,000
Quick ratio	21.47
Working capital	$254.7M
Working capital turnover	0.03

Metric

Value

Asset turnover

0.03

Current assets

$266.9M

Current liabilities

$12.2M

Current ratio

21.96

Net working capital

$-279,000

Quick ratio

21.47

Working capital

$254.7M

Working capital turnover

0.03

Metric	Value
Buyback yield / dilution	33.15%
Dividend yield	0%
Shareholder yield	33.15%

Metric

Value

Buyback yield / dilution

33.15%

Dividend yield

Shareholder yield

33.15%

Metric	Value
150-day SMA	$11.07
1D price change	1.36%
1M price change	-0.34%
1M total return	-0.34%
1W price change	1.58%
1W total return	1.58%
1Y price change	-22.95%
1Y return CAGR	-22.97%
1Y total return	-22.95%
20-day SMA	$11.31
200-day SMA	$12.15
3M price change	13.42%
3M total return	13.42%
3Y price change	-58.13%
3Y return CAGR	-25.19%
3Y total return	-58.13%
50-day SMA	$11.26
50-day SMA vs 200-day SMA	50under200
52-week high	$22.55
52-week high date	2025-12-08
52-week low	$9.69
52-week low date	2026-08-04
5Y price change	-71.11%
5Y return CAGR	-21.99%
5Y total return	-71.11%
6M price change	5.18%
6M total return	5.18%
All-time high	$88.80
All-time high date	2020-12-08
All-time low	$9.12
All-time low date	2025-04-09
Average true range (ATR)	$0.49
Average volume	162.4K
Beta (1Y)	1.75
Beta (2Y)	1.32
Beta (5Y)	1.12
Change from 52-week high	-48.65%
Change from 52-week low	19.51%
Change from all-time high	-86.96%
Change from all-time low	26.97%
Change from open	2.12%
Day's gap	-0.79%
Dollar volume	$1.6M
High price	$11.77
Low price	$11.34
Monthly RSI	38.47
Open price	$11.34
Position in 52-week range	55.81%
Premarket change	-0.04%
Premarket close	$11.43
Premarket price	$11.42
Previous close	$11.43
Price vs 150-day SMA	4.63%
Price vs 20-day SMA	2.39%
Price vs 200-day SMA	-4.66%
Price vs 50-day SMA	2.81%
Relative volume	0.83
Return from IPO open	-45.2%
Return from IPO price	-28.59%
RSI	55.14
Sharpe ratio	-0.36
Sharpe ratio (3Y)	-0.01
Sharpe ratio (5Y)	0
Sortino ratio	-0.39
Sortino ratio (3Y)	0.07
Sortino ratio (5Y)	0.08
Volume	134.4K
Weekly RSI	49.16
YTD price change	-43.12%
YTD total return	-43.12%

Metric

Value

150-day SMA

$11.07

1D price change

1.36%

1M price change

-0.34%

1M total return

-0.34%

1W price change

1.58%

1W total return

1.58%

1Y price change

-22.95%

1Y return CAGR

-22.97%

1Y total return

-22.95%

20-day SMA

$11.31

200-day SMA

$12.15

3M price change

13.42%

3M total return

13.42%

3Y price change

-58.13%

3Y return CAGR

-25.19%

3Y total return

-58.13%

50-day SMA

$11.26

50-day SMA vs 200-day SMA

50under200

52-week high

$22.55

52-week high date

2025-12-08

52-week low

$9.69

52-week low date

2026-08-04

5Y price change

-71.11%

5Y return CAGR

-21.99%

5Y total return

-71.11%

6M price change

5.18%

6M total return

5.18%

All-time high

$88.80

All-time high date

2020-12-08

All-time low

$9.12

All-time low date

2025-04-09

Average true range (ATR)

$0.49

Average volume

162.4K

Beta (1Y)

1.75

Beta (2Y)

1.32

Beta (5Y)

1.12

Change from 52-week high

-48.65%

Change from 52-week low

19.51%

Change from all-time high

-86.96%

Change from all-time low

26.97%

Change from open

2.12%

Day's gap

-0.79%

Dollar volume

$1.6M

High price

$11.77

Low price

$11.34

Monthly RSI

38.47

Open price

$11.34

Position in 52-week range

55.81%

Premarket change

-0.04%

Premarket close

$11.43

Premarket price

$11.42

Previous close

$11.43

Price vs 150-day SMA

4.63%

Price vs 20-day SMA

2.39%

Price vs 200-day SMA

-4.66%

Price vs 50-day SMA

2.81%

Relative volume

0.83

Return from IPO open

-45.2%

Return from IPO price

-28.59%

RSI

55.14

Sharpe ratio

-0.36

Sharpe ratio (3Y)

-0.01

Sharpe ratio (5Y)

Sortino ratio

-0.39

Sortino ratio (3Y)

0.07

Sortino ratio (5Y)

0.08

Volume

134.4K

Weekly RSI

49.16

YTD price change

-43.12%

YTD total return

-43.12%

Metric	Value
Float	17.8M
Float percentage	89.63%
Shares change (QoQ)	0.87%
Shares change (YoY)	-33.15%
Shares held by insiders	3.26%
Shares held by institutions	90.5%
Shares outstanding	19.8M
Short % of float	6.47%
Short % of shares	5.8%
Short ratio	6.4 days

Metric

Value

Float

17.8M

Float percentage

89.63%

Shares change (QoQ)

0.87%

Shares change (YoY)

-33.15%

Shares held by insiders

3.26%

Shares held by institutions

90.5%

Shares outstanding

19.8M

Short % of float

6.47%

Short % of shares

5.8%

Short ratio

6.4 days

Keros Therapeutics, Inc. (KROS)

Price

Financial snapshot

Fair-value bridge

Latest news · KROS

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All KROS indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on KROS

Frequently asked questions